EMA — authorised 26 September 2018
- Marketing authorisation holder: Eli Lilly Nederland B.V.
- Status: approved
🇪🇺 Verzenio in European Union
EMA authorised Verzenio on 26 September 2018
Marketing authorisation
Verzenio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Verzenio approved in European Union?
Yes. EMA authorised it on 26 September 2018.
Who is the marketing authorisation holder for Verzenio in European Union?
Eli Lilly Nederland B.V. holds the EU marketing authorisation.